[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566693":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":48,"collaborators":50,"id":53,"slug":10,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"University of Wisconsin, Madison","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Neonates with PDA",null,[12],"Device: Near Infrared Spectroscopy",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","Near Infrared Spectroscopy","Application of regional NIRS sensors to brain and kidney sites in the first 72 hours after birth to monitor regional tissue oxygenation.",[9],[20],"NIRS",[22],{"name":23,"affiliation":5,"role":24},"Matthew Harer, MD","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Paige Condit, MD","CONTACT","616-481-9914","pcondit@wisc.edu",{"name":32,"role":28,"phone":10,"phoneExt":10,"email":33},"Meg Baker","meg.baker@wisc.edu",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":10},"Meriter Hospital, Inc.","RECRUITING","Madison","Wisconsin","53715","United States",{"type":43,"coordinates":44},"Point",[45,46],-89.40123,43.07305,{"lat":46,"lon":45},{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[51],{"name":52,"class":6},"The Gerber Foundation","100566693",false,"NCT06658496","PDA for Kidneys Study","Development of a Novel Kidney-focused Approach to Treatment of a Patent Ductus Arteriosus (PDA) in Vulnerable Preterm Neonates - A Pilot Study","PDA4K","Inclusion Criteria:\n\n* Delivered at \\\u003C32 weeks' gestation\n* ≤72 hours of age\n* Inpatient at Meriter Hospital, Inc. NICU\n* At least one parent\u002Fguardian is able to provide parental permission in English or Spanish\n\nExclusion Criteria:\n\n* Major congenital anomalies of kidney\n* Attending physician's discretion to not place NIRS sensors due to clinical concerns\n* In the PI or Co-I's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life\n* Birth parent aged \\\u003C18","ALL","1 Minute","7 Days",{"count":64,"type":65},45,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury.\n\nResearchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.",[69,70],"Patent Ductus Arteriosus","Congenital Heart Disease",[72],"neonate","2026-05-12",{"date":75,"type":76},"2026-05-15","ACTUAL",{"date":78,"type":76},"2024-12-19",{"date":80,"type":65},"2027-05",{"name":5,"class":6},1]